Barber Financial Group Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% during the first quarter, Holdings Channel reports. The fund owned 1,677 shares of the healthcare conglomerate’s stock after buying an additional 188 shares during the period. Barber Financial Group Inc.’s holdings in UnitedHealth Group were worth $275,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in UNH. Lincoln Capital Corp purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $562,000. Quadrature Capital Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $1,738,000. Ibex Wealth Advisors increased its stake in shares of UnitedHealth Group by 0.6% in the fourth quarter. Ibex Wealth Advisors now owns 30,461 shares of the healthcare conglomerate’s stock worth $4,833,000 after buying an additional 193 shares in the last quarter. Wealthfront Inc. increased its stake in shares of UnitedHealth Group by 26.3% in the fourth quarter. Wealthfront Inc. now owns 34,705 shares of the healthcare conglomerate’s stock worth $5,554,000 after buying an additional 7,235 shares in the last quarter. Finally, Jackson Grant Investment Advisers Inc. increased its stake in shares of UnitedHealth Group by 0.4% in the fourth quarter. Jackson Grant Investment Advisers Inc. now owns 1,093 shares of the healthcare conglomerate’s stock worth $175,000 after buying an additional 4 shares in the last quarter. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at 194.78 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $195.41. The company’s 50-day moving average is $186.80 and its 200-day moving average is $173.05. The firm has a market cap of $191.86 billion, a PE ratio of 23.40 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Barber Financial Group Inc. Acquires 188 Shares of UnitedHealth Group Incorporated (UNH)” was reported by Daily Political and is the property of of Daily Political. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/08/barber-financial-group-inc-acquires-188-shares-of-unitedhealth-group-incorporated-unh.html.

UNH has been the topic of a number of recent analyst reports. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. Deutsche Bank AG reissued a “buy” rating and issued a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Sanford C. Bernstein reissued an “outperform” rating and issued a $190.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 10th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. One research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $200.24.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,540 shares of company stock valued at $2,873,320. 0.89% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.